LLOYD A ROWLAND

CIK 1236395 · General Counsel · last filed 2025-03-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$381.5K

Companies

3

Total Filings

51

Lifetime Open-Market Net

-$1.28M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CTMX General Counsel 120,594 $3.01 $363.0K $46.0K 19 2025-03-20
XNCR Sr. V.P. and General Counsel 1,501 $12.33 $18.5K $0 5 2016-01-28
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted VP, Chief Compliance Officer 39,091 -$1.33M 26 2012-07-26

Recent Filings · Page 2 of 6

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-07-21 CTMX Mixed +9,398 -$8.0K EDGAR
2022-02-04 CTMX Grant (A) +22,500 $0 EDGAR
2021-10-26 CTMX Grant (A) $0 EDGAR
2021-03-02 CTMX Grant (A) $0 EDGAR
2020-02-19 CTMX Grant (A) $0 EDGAR
2019-06-04 CTMX Grant (A) +1,812 $14.9K EDGAR
2019-03-05 CTMX Buy (P) +9,000 $93.0K EDGAR
2019-01-29 CTMX Grant (A) $0 EDGAR
2018-12-06 CTMX Grant (A) +979 $11.5K EDGAR
2016-01-28 XNCR Grant (A) $0 EDGAR
Showing 1120 of 51
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.